Ібранс, Реампла Palbociclib 125 mg 21 Tablets Pfizer \r\n \r\n All Europe delivery. Shipping time 7-10 days. Price for shipping individual for each country. Usually 40-50 euro. Payment when sending the goods \r\n \r\n Ibrance is indicated for the treatment of hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2 (HER2) negative advanced or metastatic breast cancer in combination with: \r\n letrozole as initial hormonal therapy in postmenopausal women; \r\n Fulvestrant in women with disease progression after endocrine therapy. \r\n The indication for use in combination with letrozole is approved under an accelerated approval procedure based on progression-free survival. A full approval procedure for this indication is...
Ibrance / Reampla (palbociclib) 125 mg, 21 tablets, Pfizer
Article:
In Stock
-
All Europe delivery. Shipping time 7-10 days. Price for shipping individual for each country. Usually 40-50 euro. Payment when sending the goods
- Ibrance is indicated for the treatment of hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2 (HER2) negative advanced or metastatic breast cancer in combination with:
- letrozole as initial hormonal therapy in postmenopausal women;
- Fulvestrant in women with disease progression after endocrine therapy.
- The indication for use in combination with letrozole is approved under an accelerated approval procedure based on progression-free survival. A full approval procedure for this indication is only possible if clinical benefit is verified and described in a confirmatory trial.
- Commercial name:Ібранс, Реампла
- Сhemical name:Palbociclib
- Dosage:125 mg
- Quantity:21
- Release form:Tablets
- Производитель:Pfizer
Препарат оригінальний, дуже швидко відправили!
З оплатою без проблем!
Тільки після отримання.